Sentences with phrase «treatment of adults»

She specializes in the psychological treatment of adults, specifically, the treatment of depression and severe mental illness, including schizophrenia and chronic depressive disorder.

Mentalization based treatment programs have proved valuable in the treatment of adults with borderline personality disorder (Bateman and Fonagy, 2013), as well as in work with adolescents who self - harm (Rossouw and Fonagy, 2012).

For a time, he specialized in the treatment of adults and adolescents with personality diagnoses.

She specializes in the treatment of adults, adolescents, couples, and families, with a special interest in complex trauma, anxiety, depression, and relationship issues.

Introduction to the special issue on research on treatment of adults sexually abused in childhood.

She specializes in the treatment of adults with anxiety, depression and life stress.

While clinically trained in evaluation, assessment and treatment of adults and children of all ages, I have specialized in early childhood mental health.

This grant provides additional support to the Australian Centre for Posttraumatic Mental Health to update and revise the Australian Centre for Posttraumatic Mental Health Guidelines for the Treatment of Adults with Acute Stress Disorder (ASD) and Posttraumatic Stress Disorder (PTSD) to ensure they remain current and are based on the best available and most recent evidence.

However, a recent report found that the rate of 12 - month treatment of adults with suicidal behavior in 21 countries averaged 40 % and was higher in the United States (63 % -82 %).43, 44 The slightly higher rate of treatment observed in the present study than in these adult studies reflects the fact that we examined lifetime treatment rather than 12 - month treatment and that the prevalence of mental disorders among those with suicidal behaviors, which is associated with increased probability of treatment, 45 was higher in the NCS - A than in the other studies.

«20 + years of professional experience in the treatment of adults and adolescents.

Treatment of adults, families, children and adolescents with psychiatric and addiction -LSB-...] Continue Reading →

Our physicians also provide outpatient evaluation and treatment of adults with allergic and immune disorders, particularly primary immunodeficiency, and consults for these patients who are admitted to Stanford University Medical Center.

lowering the threshold for drug treatment of adults with a calculated 10 - year CVD risk ≥ 10 percent, or otherwise high risk, for example, people with diabetes or renal disease, from 140/80 mmHg to 130/80 mmHg.

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder.

For the treatment of adults with overactive bladder, the G - BA specified seven different drugs as appropriate comparator therapy: darifenacin, fesoterodine, propiverine, solifenacin, tolterodine and trospium chloride.

Publication of the Diabetes Update coincided with the recent approval from the US Food and Drug Administration of a new dapagliflozin from AstraZeneca and Bristol - Myers Squibb for the treatment of adults with type 2 diabetes.

«Direct - acting antivirals have transformed the treatment of adults with chronic HCV, however, studies of these new therapies in children are required,» said Dr Karen Murray, University of Washington School of Medicine and Seattle Children's, Seattle, United States, and lead author of the study.

The drug dasabuvir (trade name Exviera) has been available since January 2015 for the treatment of adults with chronic hepatitis C infection.

The fixed - dose drug combination ombitasvir / paritaprevir / ritonavir (trade name Viekirax) has been available since January 2015 for the treatment of adults with chronic hepatitis C infection.

Ruxolitinib (trade name: Jakavi) has been approved since August 2012 for the treatment of adults with myelofibrosis.

Liraglutide (1.2 and 1.8 mg) is exclusively marketed globally under the brand name Victoza ® for the treatment of adults with type 2 diabetes to improve glycemic control.

The U.S. Food and Drug Administration (FDA) is expected to decide by Nov. 29 whether to approve Kite's CAR T, axi - cel, for treatment of adults with advanced lymphoma.

The new indication puts Kymriah in direct competition with Gilead Sciences» Yescarta, which was approved by the U.S. Food and Drug Administration in October for treatment of adults with diffuse large B - cell lymphoma who have failed to respond to other treatments.

In March, the U.S. Food and Drug Administration (FDA) approved BLINCYTO for the treatment of adults and children with B - cell precursor acute lymphoblastic leukemia in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1 percent.

The FDA granted approval to Yescarta ™ (axicabtagene ciloleucel, Kite / Gilead) for the treatment of adult patients with several types of non-Hogdkin large B cell lymphoma that is refractory or has relapsed after at least two previous systemic treatments.

He completed his adult psychiatry residency at Tufts Medical Center and is a board - certified psychiatrist specializing in the acute treatment of adult mood, anxiety, and...

ZEJULA is the first and only once - daily PARP inhibitor for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum - based chemotherapy.1 - 3

ZEJULA is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum - based chemotherapy.

The US Food and Drug Administration (FDA) has granted Priority Review designation for tisagenlecleucel (Kymriah), formerly known as CTL019, for treatment of adult patients with relapsed or refractory diffuse large B - cell lymphoma (DLBCL) who are ineligible for, or have relapsed after, autologous stem cell transplant.

The US FDA has granted Priority Review designation for tisagenlecleucel (Kymriah) for treatment of adult patients with relapsed or refractory diffuse large B - cell lymphoma who are ineligible for, or have relapsed after, ASCT.

TEMODAR is indicated for the treatment of adult patients with refractory anaplastic astrocytoma, i.e., patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.

TTFields have been approved by FDA for the treatment of adult patients suffering from newly diagnosed and recurrent glioblastoma.

Research Perspectives in Asthma: A Rationale for the Therapeutic Application of Magnesium, Pyridoxine, Coleus forskholii and Ginkgo biloba in the Treatment of Adult and Pediatric Asthma The Internist 1998 (Sep); 5 (3): 14 — 16 ~ FULL TEXT Combination therapy utilizing the compounds previously discussed could be the best approach for the chronic asthmatic patient; especially pediatric situations where stimulating modalities (eg.

TCP's withdrawal of its nominations and stockholder proposal follows Vanda's announcement that the U.S. Food & Drug Administration had granted marketing approval of its product, Fanapt ™ (iloperidone), for the acute treatment of adult patients with schizophrenia.

The treatment of adult heartworms (if an older puppy or dog has developed the full - blown disease) involves medication and rest and can be long, uncomfortable and potentially dangerous.

There is no scientific evidence that any treatment intended to kill adult heartworms in dogs will safely do so in cats and increase their infection survival rate.6 Administration of melarsomine, the compound labeled for treatment of adult heartworms in dogs, is not as effective in cats and its administration is frequently fatal.7, 8 For these reasons, «treatment» of feline heartworm disease focuses on controlling clinical signs related to the disease process.

So some of the events that are thought to be failure of the preventative could actually be failure of the treatment of adult heartworms.

The only product currently available for the treatment of adult heartworms is melarsomine dihydrochloride (Immiticide ®).

First, the introduction of melarsomine dihydrochloride in the mid-1990s revolutionized the treatment of adult heartworm infection by providing superior efficacy via intramuscular administration.1 The next great leap forward in heartworm treatment came with the discovery that some filarial worms harbor a type of bacteria, Wolbachia, and that elimination of these bacteria proved beneficial to the animal and reduced the complications of disease.2

The treatment of adult heartworm (Dirofilaria immitis) infection in dogs has changed significantly since the days when veterinarians» only option was injectable thiacetarsamide sodium.

Protocols for the treatment of adult heartworms are 90 - 98 % successful and if unsuccessful, your dog will need to be treated a second time.

We are a private clinical and research center, which focuses exclusively on the diagnosis and treatment of adult Attention Deficit Disorder (patient age 16 years or older) and its co-existing disorders.

The book includes guidelines for the assessment of child maltreatment, discusses therapy to address child maltreatment, and addresses treatment of adult survivors of childhood maltreatment.

In addition, as a faculty member of the University of Michigan Medical School Department of Psychiatry and the Michigan Psychoanalytic Institute, I have taught courses in the treatment of anxiety, depression, interpersonal relationships, and treatment of adult survivors of childhood abuse, for which I have received teaching awards.»

Process research in the treatment of adult victims of childhood sexual abuse.

The Sexual Recovery Institute specializes in the treatment of adult material addiction, and we offer a confidential assessment to help you move to the next step.

Not exact matches

The treatment, named Kymriah, was hailed by doctors and the life sciences community as a major advance in medicine and a boon to children and young adults with a certain form of leukemia (the group for whom the gene therapy is approved).

Today, more than half of adults in the U.S. living with mental illness do not receive treatment.

Almost six in 10 adults (57 %) say they would be willing to pay one dollar more per week in taxes to increase federal funding for the scientific research into the causes and treatment of pain.

And, more recently, we witnessed the approval of Spinraza as a treatment for spinal muscular atrophy (SMA) in adults and children this past December.